NCT Number: NCT02741843
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly
The purpose of this study is to test the effectiveness of brief face-to-face patient education in increasing uptake of influenza vaccine among Chinese elderly in the community.
Looking for future studies?
Notify MeKey information
Conditions
Age range
65 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Cantonese speaking
- Chinese
Exclusion criteria
- cognitively impaired
- unable to communicate effectively
- having known contraindication of vaccination
- institutionalized
Treatment and study plan
Primary outcomes
-
proportion of patients receiving influenza vaccination
Time frame: three working days
Secondary outcomes
-
proportion of patients receiving influenza vaccination
Time frame: five working days
-
proportion of patients receiving influenza vaccination
Time frame: seven working days
-
proportion of patients receiving influenza vaccination
Time frame: nine working days
Sponsors and collaborators
Lead sponsor
The University of Hong Kong
Other
Registry information
Official study title
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly: A Randomised Controlled Trial
Important dates
- Study start
- 2015
- Primary completion
- 2015
- First posted
- Apr 18, 2016
- Registry last updated
- May 6, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years
NCT05514002
Infections, Influenza, Human
Tucson, Arizona, United States
View Trial DetailsAn Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
NCT04494412
Arthralgia, Infections
Florence, Italy
View Trial DetailsSafety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age
NCT05501561
Infections, Influenza, Human
Tempe, Arizona, United States
View Trial DetailsA Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
NCT06087640
Infections, Influenza, Human
Birmingham, Alabama, United States
View Trial Details